1. |
郑荣寿, 孙可欣, 张思维, 等. 2015年中国恶性肿瘤流行情况分析. 中华肿瘤杂志, 2019, 41(1): 19-28.
|
2. |
LEWIS I. The surgical treatment of carcinoma of the oesophagus; with special reference to a new operation for growths of the middle third. Br J Surg, 1946, 34: 18-31.
|
3. |
Orringer MB, Marshall B, Iannettoni MD. Transhiatal esophagectomy: Clinical experience and refinements. Ann Surg, 1999, 230(3): 392-400.
|
4. |
Pritchard J. Statistical-bibliography or bibliometrics? 1969, 25(4): 348-349.
|
5. |
Hutchins BI, Baker KL, Davis MT, et al. The NIH Open Citation Collection: A public access, broad coverage resource. PLoS Biol, 2019, 17(10): e3000385.
|
6. |
郑文晖. 文献计量法与内容分析法的比较研究. 情报杂志, 2006, 25(5): 31-33.
|
7. |
朱庆华, 李亮. 社会网络分析法及其在情报学中的应用. 情报理论与实践, 2008, 31(2): 6.
|
8. |
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2021, 71(3): 209-249.
|
9. |
van der Sluis PC, van der Horst S, May AM, et al. Robot-assisted minimally invasive thoracolaparoscopic esophagectomy versus open transthoracic esophagectomy for resectable esophageal cancer: A randomized controlled trial. Ann Surg, 2019, 269(4): 621-630.
|
10. |
Tagkalos E, van der Sluis PC, Berlth F, et al. Robot-assisted minimally invasive thoraco-laparoscopic esophagectomy versus minimally invasive esophagectomy for resectable esophageal adenocarcinoma, a randomized controlled trial (ROBOT-2 trial). BMC Cancer, 2021, 21(1): 1060.
|
11. |
Li B, Zhang Y, Miao L, et al. Esophagectomy with three-field versus two-field lymphadenectomy for middle and lower thoracic esophageal cancer: Long-term outcomes of a randomized clinical trial. J Thorac Oncol, 2021, 16(2): 310-317.
|
12. |
Sihag S, Ku GY, Tan KS, et al. Safety and feasibility of esophagectomy following combined immunotherapy and chemoradiotherapy for esophageal cancer. J Thorac Cardiovasc Surg, 2021, 161(3): 836-843.
|
13. |
Wang H, Tang H, Fang Y, et al. Morbidity and mortality of patients who underwent minimally invasive esophagectomy after neoadjuvant chemoradiotherapy vs neoadjuvant chemotherapy for locally advanced esophageal squamous cell carcinoma: A randomized clinical trial. JAMA Surg, 2021, 156(5): 444-451.
|
14. |
Mariette C, Markar SR, Dabakuyo-Yonli TS, et al. Hybrid minimally invasive esophagectomy for esophageal cancer. N Engl J Med, 2019, 380(2): 152-162.
|
15. |
van Workum F, Verstegen MHP, Klarenbeek BR, et al. Intrathoracic vs cervical anastomosis after totally or hybrid minimally invasive esophagectomy for esophageal cancer: A randomized clinical trial. JAMA Surg, 2021, 156(7): 601-610.
|
16. |
di Pietro M, Canto MI, Fitzgerald RC. Endoscopic management of early adenocarcinoma and squamous cell carcinoma of the esophagus: Screening, diagnosis, and therapy. gastroenterology, 2018, 154(2): 421-436.
|
17. |
Yasuda T, Shiraishi O, Iwama M, et al. Novel esophageal reconstruction technique via transmediastinal route from posterior to anterior mediastinum after esophagectomy. J Thorac Cardiovasc Surg, 2018, 156(2): 859-866.
|
18. |
Shen Y, Zhang Y, He M, et al. Advancing gastroscope from intraluminal to extraluminal dissection: Primary experience of laparo-gastroscopic esophagectomy. Ann Surg, 2022, 275(4): e659-e663.
|